Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the pharmacokinetics, safety, and tolerability of MEDI0382 in subjects with renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• MEDI0382

Snippet

Sponsor: MedImmune LLC | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED